Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
The Oncologist|July 14, 2017
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker AnalysisMiguel Martín, José I Chacón, Antonio Antón, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trialMiguel Martín, Alvaro Rodriguez-Lescure, Cristina Reboredo, et al.The New England Journal of Medicine|December 3, 2010
Adjuvant docetaxel for high-risk, node-negative breast cancerMiguel Martín, Miguel A Seguí, Antonio Antón, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)Ana Lluch, Carlos H Barrios, Laura Torrecillas, et al.Pageof 1